Pav Rishiraj

Pav Rishiraj is an experienced professional in pharmacovigilance and patient safety, currently serving as Director, Head of Pharmacovigilance at Ipsen since January 2022. Prior to this role, Rishiraj held leadership positions at Merck KGaA, where responsibilities included Director, Head of Patient Safety & UK QPPV for the UK and Ireland, and at Sandoz as Director, Head of Drug Safety & LQPPV for the UK, Ireland, Malta, and Nordics. Rishiraj's career also includes a role as Interim Global Safety Surveillance and Risk Management Manager at Mylan, and various roles in pharmacovigilance at leading companies such as Johnson & Johnson, GSK, Schering-Plough, and Sanofi. Rishiraj holds a Master of Science in Pharmacology from King's College London and a Bachelor of Science in Biomedical Sciences from Sheffield Hallam University.